Table 3: Intermediate or high-risk patient's sub analysis.

Global Gleason < 7 Gleason > 6 p
Age 63.79 ± 7.5 63.29 ± 7.5 65.59 ± 7.4 0.2
Prostate volume Prostate volume 47.86 ±24.8 42.18 ± 21.7 0.33
PSAd 0.19 ± 0.19 0.18 ± 0.20 0.22 ± 0.16 0.48
PSA 6.06 ± 1.9 5.7 ± 1.9 67.0 ± 1.6 0.01
Free PSA 1.01 ± 0.61 0.99 ± 0.64 1.08 ± 0.48 0.52
Ratio PSA 0.16 ± 0.07 0.16 ± 0.07 0.15 ± 0.04 0.27
-2proSPA 16.88 ± 11.15 15.13 ± 9.09 23.17 ± 15.2 0.02
Ratio -2proPSA 1.81 ± 1.08 1.75 ± 0.99 2.03 ± 1.34 0.26
PHI 44.02 ± 26.04 41.03 ± 23.5 54.78 ± 31.7 0.02